Bristol-Myers Squibb to Acquire Adnexus Therapeutics
- Details
- Category: Bristol-Myers Squibb

Protherics signs ReGel⢠licensing agreement with Myungmoon Pharm
- Details
- Category: Business

Lundbeck in-licenses Circadin®, a drug approved for the treatment of primary insomnia
- Details
- Category: Lundbeck

First in a New Oral Class of HIV Medicines in 10 Years
- Details
- Category: Pfizer

Sanofi-aventis Enters the Dow Jones Sustainability World Indexes
- Details
- Category: Sanofi

Tasigna® recommended for European approval to treat rare form of leukemia
- Details
- Category: Novartis

European licence for Roche HIV drug Viracept recommended for re-instatement
- Details
- Category: Roche

More Pharma News ...
- Campath® Include First-line Treatment for Leading Form of Adult Leukemia
- Teva Receives Positive Feedback on Second AOK Tender in Germany
- Novo Nordisk receives approval in the EU for use of NovoRapid® in elderly people
- Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug
- AstraZeneca launches and prices a EUR750 million debut eurobond
- Study Results for Aclidinium Bromide, a Novel Anticholinergic
- Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds